Market Tracker

08/28 6:01pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

7.67
Delayed Data
As of Aug 28
 -0.16 / -2.04%
Today’s Change
4.26
Today|||52-Week Range
11.15
+1.46%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close7.83
Today’s open7.75
Day’s range7.45 - 7.96
Volume1,085,350
Average volume (3 months)1,505,076
Market cap$534.5M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-1,037.50%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+464.45%
P/E ratio187.8
Price/Sales11.63
Price/Book4.28

Competitors

 Today’s
change
Today’s
% change
COCPCocrystal Pharma Inc-0.01-1.26%
CARACara Therapeutics In...+0.25+1.32%
SRNESorrento Therapeutic...+0.33+2.48%
SPPISpectrum Pharmaceuti...+0.11+1.47%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 9, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$44.4M
Annual profit (last year)$4.4M
Net profit margin9.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
CFO, Treasurer, Principal Accounting Officer &
VP
Angelo William Lovallo
Corporate headquarters
Tarrytown, New York

Forecasts